DOCS Doximity, Inc.
DOCS financial statements, revenue, balance sheet, cash flow, and SEC filings
▼ Company Profile
▼ Key Metrics (TTM)
As of Jun 30, 2026Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
| Metric | FY2026 📄 | FY2025 📄 | FY2024 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| Revenue | $644.86M | $570.40M | $475.42M |
| Cost of Revenue | $70.33M | $55.87M | $50.67M |
| Gross Profit | $574.54M | $514.53M | $424.75M |
| OPERATING EXPENSES | |||
| R&D Expense | $130.70M | $93.04M | $81.98M |
| SG&A Expense | $65.27M | $45.67M | $37.83M |
| Other Operating Expenses (derived) | $163.65M | $148.02M | $141.07M |
| Operating Income | $214.92M | $227.80M | $163.88M |
| NON-OPERATING INCOME / EXPENSE | |||
| Other Income/Expense | $-806.00K | $-247.00K | $62.00K |
| Pretax Income | $250.01M | $263.57M | $185.20M |
| Income Tax | $53.95M | $40.39M | $37.62M |
| Net Income | $196.05M | $223.19M | $147.58M |
| PER SHARE & SUPPLEMENTAL | |||
| Diluted EPS | $0.98 | $1.11 | $0.72 |
| Diluted Shares | 199.05M | 201.21M | 205.73M |
| EBITDA | $229.30M | $238.46M | $174.14M |
| Depreciation & Amortization | $14.38M | $10.66M | $10.27M |
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | $219.18M | $209.61M | $96.79M |
| Accounts Receivable | $144.78M | $128.35M | $101.33M |
| Other Current Assets | $50.88M | $44.60M | $48.71M |
| Current Assets | $944.26M | $1.09B | $912.94M |
| PP&E (Net) | $18.08M | $13.66M | $12.32M |
| Goodwill | $84.97M | $67.94M | $67.94M |
| Intangible Assets | $35.33M | $23.07M | $27.32M |
| Other Noncurrent Assets | $1.92M | $2.12M | $1.46M |
| Noncurrent Assets | $179.42M | $175.69M | $166.43M |
| Total Assets | $1.12B | $1.26B | $1.08B |
| LIABILITIES | |||
| Accounts Payable | $4.01M | $1.36M | $2.25M |
| Other Current Liabilities | $8.93M | $5.56M | $4.36M |
| Current Liabilities | $154.97M | $156.26M | $147.25M |
| Other Noncurrent Liabilities | $9.40M | $9.38M | $7.22M |
| Noncurrent Liabilities | $17.88M | $25.43M | $30.73M |
| Total Liabilities | $172.85M | $181.68M | $177.98M |
| EQUITY | |||
| Common Stock | $183.00K | $189.00K | $187.00K |
| Additional Paid-in Capital | $1.00B | $894.23M | $823.89M |
| Retained Earnings | $-51.06M | $186.89M | $79.99M |
| Accumulated OCI | $28.00K | $1.32M | $-2.66M |
| Total Equity | $950.84M | $1.08B | $901.40M |
| Total Liabilities & Equity | $1.12B | $1.26B | $1.08B |
| SUPPLEMENTAL | |||
| Shares Outstanding | 183.06M | 188.88M | 186.56M |
| Check: A − (L + E + NCI) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $326.46M | $273.27M | $184.10M |
| Capital Expenditures | $0 | $0 | $147.00K |
| Cash from Investing | $147.17M | $-29.30M | $31.19M |
| Cash from Financing | $-464.06M | $-131.14M | $-276.52M |
| Free Cash Flow | $326.46M | $273.27M | $183.95M |
| Beginning Cash (CFS) | $209.61M | $96.79M | - |
| Net Change in Cash | $9.56M | $112.83M | - |
| Effect of FX on Cash | - | - | - |
| Calculated Ending Cash | $219.18M | $209.61M | - |
| Cash per BS | $219.18M | $209.61M | $96.79M |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $219.18M | $209.61M | $96.79M |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log InQuarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
What is Doximity, Inc.'s annual revenue?
Doximity, Inc. reported $655.57M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.
Is Doximity, Inc. profitable?
Yes. Doximity, Inc. reported $167.05M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.
Fundamentals Hub